Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Standard Essential Patents

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Search results

Webinar | April 21, 2016

Biosimilars Litigation: Past, Present and Future

Q&A | April 21, 2016

Law360 Trial Pros: Fish & Richardson's Ruffin Cordell

Blog | April 20, 2016

EDTX denies Daubert motions involving apportionment, entire market value rule, license agreements, and patent valuations

Podcast | April 19, 2016

Fish Post-Grant Radio: Episode #1: Dorothy Whelan

Event | April 16, 2016

2016 Creative Alliance 21st Birthday Marquee Ball

Event | April 13, 2016

TechAfterHours

Webinar | April 13, 2016

Multiple Parties, Multiple Petitions Part II

Blog | April 11, 2016

Claims Directed to Detection of Gene Variants Patent-Ineligible, Notwithstanding Mental Activity Requirement

Event | April 10, 2016

Pharma & Biotech Patents: A Hatch-Waxman & BPCIA (Biosimilars) Immersion Course Encompassing Prosecution Strategies, FDA Regulation, Post-Grant Challenge, and Litigation

News | April 08, 2016

Fish & Richardson Obtains Full Federal Circuit Reversal for Cutsforth, Inc. After Faulty Inter Partes Review

News | April 05, 2016

Fish & Richardson Announces 2016 1L Diversity Fellows

Event | April 05, 2016

Boston Seminar Series: Latest Developments in Post-Grant Proceedings for Biosimilars